ライフサイエンスコーパス: biochip

1 ty purification; (iii) biotin-mediated ChIP (bioChIP).

2 highly specific biological recognition (BSW biochip).

3 ept to produce the flow-through microfluidic biochip.

4 rate the usefulness and potential of the DNA biochip.

5 iguration was miniaturized and fitted onto a biochip.

6 was also improved using this newly designed biochip.

7 validate the results obtained by the new DNA-biochip.

8 tive antibodies to construct a GNR multiplex biochip.

9 positive (SK-BR-3) cells on the Test Cancer BioChip.

10 poration into high-throughput biosensors and biochips.

11 as AMS, MALDI-MS or protein microarray-type biochips.

12 s, and the development of protein arrays and biochips.

13 mmobilized on the surface of the GaAs/AlGaAs biochips.

14 and precise voltage signal between different biochips.

15 photocorroding GaAs/AlGaAs quantum well (QW) biochips.

16 ly used methods for quantitative analysis on biochips.

17 es multiplexed biodetection and multi-marker biochips.

18 development of next generation point-of-care biochips.

19 iffused methods for quantitative analysis on biochips.

20 ts and for the design of cell-free synthetic biochips.

21 high sensitivity obtained by the OLED based biochip (0.37ng/mul) and the short time required for the

22 sive data set of images generated by the SCD BioChip, a microfluidic assay which injects clinical who

23 platform, comprising low-cost chemiresistive biochips, a portable electronic readout, and an Android

24 y and image processing of a microarray glass biochip, affordable to be single-used in medical applica

25 we assembled dense DNA polymer brushes on a biochip along a density gradient and directly measured t

26 ly sensitive surface plasmon resonance (SPR) biochip and a simple portable imaging setup for label-fr

27 in for E. coli) were also similar to silicon biochip and commercial electrode sensors.

28 g potential for future applications, such as biochip and in situ imaging, which require reusability,

29 tiantigen (RBD peptide and N protein) sensor biochip and reaches detection limits in the low ng mL(-1

30 proach by characterizing a protein monolayer biochip and the depth distribution of proteins in human

31 density information storage and miniaturized biochips and biosensors, among others.

32 attachment to the surface of immune-reactive biochips and during the SPR analysis.

33 proach, based on electrically switchable DNA biochips and single-molecule mass analysis, was used to

34 abling multiplexed detection and multimarker biochips), and significant cost reduction.

35 ulti-analyte physiological status monitoring biochip, and iv) the development of a bioanalytical Wien

36 icrotechnology, cell culture in microfluidic biochips, and metabolic profiling opens the development

37 ng technologies including mass spectrometry, biochips, and single molecule analysis are included in t

38 g technologies (including mass spectrometry, biochips, and single-molecule analysis) will also be exa

39 g molecules is an essential prerequisite for biochip- and diagonostic assays.

40 A1 antibody (Ab(ApoA1))-functionalized chip (biochip(ApoA1)) and self-linkable peroxidase-mimicking,

41 and capturing ApoA1 proteins captured on the biochip(ApoA1), the PMGO was functionalized with Ab(ApoA

42 gnostics, therapeutics, and highly sensitive biochip applications.

43 r and cellular interactions occurring on the biochip are monitored by surface plasmon resonance (SPR)

44 n the design and fabrication of microfluidic biochips are protein binding on the channel surface and

45 Integrated biochips are the ideal solution for producing portable d

46 This approach is anticipated to be a useful biochip array amenable to low-cost point-of-care devices

47 ological-electronic-device construction, and biochip-array fabrication.

48 molecular machine, including fabrication of biochip arrays, and experimental studies of its ability

49 synthesized and integrated with microfluidic biochips as point-of-care sensing platforms.

50 We have fabricated a flow-through biochip assembly that consisted of two different microch

51 mutant DNA in 100 normal sequences with the biochip assembly.

52 terized a miniaturized, highly-sensitive DNA biochip based on a deep-blue organic light-emitting diod

53 we designed and characterized a miniaturized biochip based on a novel deep-blue organic light-emittin

54 can be further transformed onto miniaturized biochips based on the nanosized optical transducer to al

55 We present here an innovative biochip, based on direct differential carbohydrate recog

56 The disposable quartz biochip, based on microelectronic components found in ev

57 the potential to enable not only autonomous biochip-based immunoassays for remote testing but also c

58 rate was further increased on a Hsp60-coated biochip by 60% when a dielectrophoresis force was applie

59 he Center for Bioelectronics, Biosensors and Biochips (C3B(R)) has subsequently been located at Clems

60 The biochip can also be adapted to enumerate other specific

61 c systems because the price and size of each biochip can be effectively reduced by using fully polyme

62 The biofunctionality of the ZIF-8-protected biochip can be restored by a simple water-rinsing step,

63 onally, some of the techniques, such as cDNA biochip, cannot define the sub-population of tissue from

64 rm known as the digital array, a nanofluidic biochip capable of accurately quantitating genes of inte

65 The best biochip configuration has been successfully applied to t

66 The SPR biochip consists of several capped nanoslit arrays with

67 alyzer and a standard compact disc (CD) as a biochip containing immobilized protein molecules.

68 The packaging of biochips containing pre-loaded proteins is also a challe

69 This pluggable biochip could be incorporated with many applicable devic

70 teria after 12-weeks storage of freeze-dried biochips, demonstrating the biochip potential as a simpl

71 iniature diode laser with the self-contained biochip design allows for a compact system that is readi

72 dinone phosphate) is combined with a compact biochip detection system, which includes a miniature dio

73 be a new paradigm in high-throughput protein biochip development in the era of nano-biosensing.

74 The biochip device has sensors, amplifiers, discriminators,

75 A fully integrated biochip device that consists of microfluidic mixers, val

76 trate is an essential prelude to any hybrid "biochip" device, but a second and equally important cond

77 s in a new generation of miniaturized, smart biochip devices.

78 tiae and Chlamydia trachomatis with a single biochip, enabling a quick screening thanks to the presen

79 A blood drop deposit at the tip of the biochip established a simple biological protocol.

80 Integrated biochips exploit a multi-disciplinary approach to produc

81 the developed material in the biosensors and biochips field, DNA probes were electrografted, using di

82 Flow-based microfluidic biochips (FMBs) are widely used in biomedical research a

83 nctioning of an electrochemical microfluidic biochip for the detection of OA.

84 Based on a single-DNA-molecule biochip for the parallelization of tethered particle mot

85 od is based on a combination of a single-DNA biochip for the parallelization of tethered particle mot

86 lts obtained in conventional diffusion-based biochips for a given time (2 h).

87 The biochip has been integrated to a microfluidics system an

88 ene expression in localized DNA brushes on a biochip has been shown to depend on gene density and ori

89 The spiral biochip identifies and addresses key challenges of the n

90 An innovative protein biochip immunoassay was used to quantitate and compare s

91 functional and ultrasensitive plasmonic DNA biochip in molecular beacon fashion.

92 e and further enhance the sensitivity of the biochip in the RF DNA detection.

93 lso evaluated in the context of carbohydrate biochips in which surface coating with carbohydrates is

94 e report a polymer/paper hybrid microfluidic biochip integrated with loop-mediated isothermal amplifi

95 large number of living single cells using a biochip integrating ultrasensitive nanoplasmonic substra

96 rference contrast microscopy analysis of SCP-biochip interactions revealed a strong influence of link

97 developed arsenic-sensitive electrochemical biochip is easy to use and outperforms state-of-the-art

98 the thin flexible surfaces that make up the biochip is explored in this work.

99 Biochip measurements have shown excellent correlation wi

100 od has potential for broader applications in biochip medicine.

101 DNA microarray synthesis based on a flexible biochip method.

102 ased on indirect immunofluorescence, we used biochip mosaics of frozen brain sections (rat, monkey) a

103 triction model was applied to a miniaturized biochip nanovolume reactor to accurately characterize DN

104 Biochips of various geometries were tested and evaluated

105 The TB-Biochip oligonucleotide microarray system is a rapid sys

106 with the paper-free non-hybrid microfluidic biochip over a period of three months, the hybrid microf

107 Biochips performing in-situ multiplex immunoassays are a

108 A rapid (<20min) gel-membrane biochip platform for the detection and quantification of

109 end a previously developed microfluidic-free biochip platform to quantitatively reconstitute interact

110 The applicability of the device as a biochip platform was further illustrated by analytical m

111 onucleotide probes on an in situ synthesized biochip platform, we demonstrate that mismatches in the

112 of freeze-dried biochips, demonstrating the biochip potential as a simple minimal maintenance "plug-

113 finity purification of protein complexes and bioChIP, respectively.

114 Bacteria captured on the surface of biochips retard the PL maximum, while growth of these ba

115 Furthermore, we have shown the biochip's utility for improved sepsis diagnosis by combi

116 The biochip sensitivity is also found be independent of orie

117 specific detection of L. monocytogenes on a biochip sensor platform.

118 n removes baseline shifts within and between biochip sensors, allowing accurate and precise voltage s

119 Further analysis using bioChIP-seq revealed that GCM1 and OTX2 act as pioneer f

120 -effective approach compatible with flexible biochip sizes.

121 d limitations in cost and reliability of the biochip, specificity of the antibody against Asian in-fi

122 rect photopatterning of electrodes useful as biochip substrates.

123 Herein, we propose a DNA-based biochip suitable for cell-type analysis in a label-free

124 The AFM analysis of the biochip surface allowed metrological analysis of capture

125 In this study, we used a protein biochip surface enhanced laser desorption/ionization mas

126 by the differential adhesion between SCP and biochip surface, supported by automated image analysis a

127 molecular species and their interactions on biochip surfaces.

128 The Cancer BioChip System (CBCS) allows for the simultaneous, quant

129 ed portable bioaerosol sampler and miniature biochip system detected 100 B. globigii spores, correspo

130 With this small sample set, the TB-Biochip system displayed a sensitivity of 80% and a spec

131 the micron-sized particle trap integrated in biochip systems using a planar structure to generate an

132 We employed a Test Cancer BioChip that contains silencing RNAs (siRNAs) targeting

133 Here, we report a nanoparticle-based biochip that could capture circulating EVs without isola

134 A biochip that has two sets of Au electrode arrays, each c

135 Printable multi-marker biochips that enable simultaneous quantitative detection

136 lysis are implemented within sealed flexible biochips, time-consuming processing steps are not requir

137 Here, we report a PoC microfluidic biochip to enumerate leukocytes and quantify nCD64 level

138 TGA) was used on the surface of the proposed biochip to form a thiolate-modified sensing surface for

139 Exposure of the enzyme decorated biochip to glyphosate containing samples causes formatio

140 In clinical studies, we have used PoC biochip to monitor leukocyte counts and nCD64 levels fro

141 rated the possibility of using the developed biochip to preconcentrate and rotate RBC clusters in 3D.

142 which harnesses surface acoustic wave (SAW) biochips, to detect HIV in a finger prick of blood withi

143 A 28-well plate biochip was built on a glass substrate by sequential dep

144 an interdigitated array microelectrode based biochip was developed and validated with pure AI H5 viru

145 An innovative gold nanorod (GNR) array biochip was developed to systematically investigate the

146 iod of three months, the hybrid microfluidic biochip was found to have a much longer shelf life.

147 This newly-designed biochip was then used to measure the electrochemical fea

148 The biochips were functionalized with self-assembled monolay

149 low are achievable with the magnetoresistive biochip, when pre-processing and chemometrics are used.

150 This is relevant to future protein biochips where dilute arrays of protein binding sites, e

151 In this work we present a simple biochip which can be used to trap and rotate a single ce

152 e surface enhanced Raman spectroscopy (SERS) biochip which enables direct and simultaneous identifica

153 Here, we report a 3D biochip with a 2D layout of 1024 DNA compartments as art

154 y, we developed a novel plastic microfluidic biochip with an on-chip anesthetic biosensor that was ch

155 The proposed disposable microfluidic biochip with an on-chip anesthetic biosensor using MIPs

156 We show that LPHN-CHDC biochip with signal amplification capability could selec

157 The illumination of a QW biochip with the above bandgap radiation leads to format

158 This method can easily bond biochips with complex flow patterns.

159 onal instruments, the developed microfluidic biochips with on-chip MIP biosensors present the advanta